SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-065983
Filing Date
2021-05-13
Accepted
2021-05-13 16:32:36
Documents
2
Period of Report
2021-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2116150d1_8k.htm 8-K 17650
2 EXHIBIT 99.1 tm2116150d1_ex99-1.htm EX-99.1 18639
  Complete submission text file 0001104659-21-065983.txt   37673
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35963 | Film No.: 21920155
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences